U.S. Pharma Stock News

Unum Group (NYSE:UNM) has approved material amendments to its corporate bylaws, reshaping rules for shareholder meetings, proposals, director nominations, and indemnification. The company has also seen recent insider selling activity by a senior executive, alongside a pattern of insider sales over the past year. These governance changes and insider transactions arrive together, raising questions for investors about internal priorities and board level decision making. Unum Group, a provider...

In early March 2026, Century Aluminum Company disclosed it could not file its upcoming 10-K with the SEC by the required deadline, even as it highlighted strong first-quarter adjusted EBITDA guidance and progress restarting key smelter capacity in the United States and Iceland. This combination of filing delays alongside operational momentum and capacity expansions creates a complex picture for investors weighing regulatory risk against improving fundamentals and industry tailwinds. Next,...

Old Dominion Freight Line recently reported quarterly results showing that revenue of US$1.31 billion was broadly in line with expectations, while adjusted operating income and EBITDA were stronger than anticipated amid a softer freight backdrop. At the same time, the company maintained a 99% on-time service rate, earned industry awards, and renewed diversity partnerships, reinforcing an emphasis on service quality and workforce inclusion even as earnings per share have trended lower over...

In recent months, Grand Canyon Education has reported weaker student growth and stagnant profitability, raising concerns among investors about the resilience of its education services model. An interesting detail is that analysts now expect free cash flow margins to remain flat, signaling limited room for near-term financial improvement despite prior optimism. Next, we’ll examine how this softer student growth trend could alter Grand Canyon Education’s previously supportive investment...

If you are trying to figure out whether Federal National Mortgage Association at US$6.10 is offering value right now, you are in the right place. This article is all about what the current price actually implies. The stock has been volatile recently, with a 4.7% decline over the last 7 days, a 26.6% decline over 30 days, and a 44.5% decline year to date, even though the 3 year return is very large and the 5 year return stands at 221.9%. This article was prompted to give ongoing coverage of...

EHang Holdings (NasdaqGM:EH) just posted its FY 2025 third quarter numbers, reporting revenue of C¥92.5 million and a basic EPS loss of C¥1.11, with trailing twelve month revenue at C¥430.0 million and a basic EPS loss of C¥3.98. The company has seen quarterly revenue move between C¥26.1 million and C¥164.3 million over the past six reported periods, while basic EPS losses have ranged from C¥0.66 to C¥1.12 per share. This sets up a story where growth expectations are balanced against still...

Axon Enterprise executives, including CEO Rick Smith, have recently carried out sizable insider stock sales in NasdaqGS:AXON. The transactions involve multiple senior leaders and represent a meaningful reduction in insider holdings. These sales are material for investors tracking governance, insider sentiment and potential shifts in management confidence or personal diversification. Axon Enterprise, traded on NasdaqGS:AXON, now sits at a share price of $496.18 after a 14.2% return over the...

Yelp stock performance after recent trading session Yelp (YELP) ended the latest trading session at US$23.83. The share price has shown mixed moves recently, including a 1 day decline, a 7 day pullback, and a gain over the past month. See our latest analysis for Yelp. That mixed near term picture sits against a weaker backdrop, with a 21.9% 3 month share price return decline and a 32.0% 1 year total shareholder return loss, which suggests recent optimism is fading as investors reassess growth...

If you are looking at JetBlue Airways and wondering whether the current share price reflects its true worth, this article will walk through the key numbers that matter for valuation. With the stock at US$4.12 and recent returns of an 8.2% decline over 7 days, a 29.1% decline over 30 days, a 10.2% decline year to date and a 26.4% decline over 1 year, plus a 40.5% decline over 3 years and an 80.4% decline over 5 years, many investors are asking if sentiment has swung too far. These moves sit...

Ziff Davis event puts recent revenue disappointment and investigation in focus Ziff Davis (ZD) is back in the spotlight after reporting a year-over-year revenue decline in Q4 2025 that conflicted with earlier guidance for accelerating growth. This has triggered shareholder losses and a law firm investigation into potential investor misinformation. See our latest analysis for Ziff Davis. At a share price of US$39.46, Ziff Davis has a 30 day share price return of 25.43% and a year to date share...

CRISPR Therapeutics (NasdaqGM:CRSP) reports strong commercial progress for its gene editing therapy CASGEVY, with higher than expected revenue contribution. The company highlights a threefold increase in projected patient initiations for 2025, signaling growing real world adoption of CASGEVY. Alongside CASGEVY traction, CRISPR Therapeutics advances new gene editing programs and partnerships, expanding its clinical pipeline. CRISPR Therapeutics, trading at $48.75, is moving further into a...

What is driving interest in Coastal Financial stock? Coastal Financial (CCB) has been in focus after reporting strong net interest income and earnings per share relative to peers, alongside the board appointment of fintech veteran Jeffrey M. Chapman. See our latest analysis for Coastal Financial. Despite the recent headlines, Coastal Financial’s 30-day share price return of 12.22% and 90-day share price return of 32.58% decline show fading near term momentum, while its 3-year and 5-year total...

If you are looking at Everus Construction Group and wondering whether the recent share price makes sense, the key question is how that price stacks up against the company’s underlying value. The stock last closed at US$112.60, with returns of 2.1% over 7 days, 9.9% over 30 days, 26.3% year to date, and 195.9% over the past year. This naturally raises questions about how expectations and risks are being priced in. Recent coverage has focused on Everus Construction Group’s role within the...

If you are wondering whether Halozyme Therapeutics at around US$63.66 offers good value today, it helps to step back and line up what the current price might be implying about the business. The stock has been choppy recently, with a 5.5% decline over the last week, a 17.2% decline over the last month, but a 92.4% return over three years and 44.3% over five years, which can leave investors unsure whether the current level reflects opportunity or higher risk. Recent coverage has focused on...

If you are wondering whether Exxon Mobil shares still offer value after a strong run, you are not alone. This article focuses squarely on what the current price may be implying. The stock last closed at US$156.12, with returns of 3.2% over 7 days, 0.4% over 30 days, 27.3% year to date, 44.3% over 1 year and 73.2% over 3 years. This naturally raises questions about how much of the story is already priced in. Recent coverage around Exxon Mobil has centered on its position as a major integrated...

If you are wondering whether Griffon is starting to look attractively priced after its recent swings, or if the share price already reflects the story, this valuation review is designed to help you frame that question clearly. The stock closed at US$70.82, with a 7 day return of an 8.5% decline, a 30 day return of a 24.6% decline, a year to date return of a 5.6% decline, but a 1 year return of 2.9% and a 3 year return that is very large compared to the starting point. Recent price moves sit...

In February 2026, Artisan Partners Asset Management Inc. reported preliminary assets under management of US$188.5 billion, split roughly evenly between its Artisan-branded funds and separate accounts and other mandates. The update underscored how the firm’s multi-team, multi-strategy lineup spans growth, value, credit, emerging markets, real estate, and custom credit solutions for global institutional and wealth clients. Now we’ll examine how this expanded, diversified US$188.5 billion asset...

Driivz, a Vontier (NYSE:VNT) company, has launched an advanced Energy Management System for electric vehicle charging operators. The new EMS is designed to optimize energy flows, support cost control, and improve capacity use across EV charging networks. For Vontier, which focuses on mobility technologies and related services, the Driivz launch fits directly into its push toward smart mobility and energy management solutions. EV charging operators are dealing with higher power needs, grid...

Graco (GGG) is in focus after unveiling its Pulse Mobile fluid management system at CONEXPO 2026, and naming longtime General Motors finance leader Sanjiv Gupta as its next Chief Financial Officer. See our latest analysis for Graco. These product and leadership updates come after a softer 30 day share price return of a 7.26% decline, while the 90 day share price return of 4.83% and 3 year total shareholder return of 35.29% suggest longer term momentum has been stronger than very recent...

If you are wondering whether CVS Health is reasonably priced at around US$76.13, you are not alone; plenty of investors are trying to work out what a fair value for the stock looks like right now. The share price return is flat to slightly weaker in the short term, with a 2.3% decline over the last 7 days and a 1.2% decline over 30 days, while the longer term picture shows a 5.0% decline year to date but a 20.3% return over 1 year, 15.0% over 3 years and 22.5% over 5 years. Recent headlines...

In recent months, Roper Technologies reported mixed Q4 2025 results and conservative 2026 guidance, while continuing to deploy about US$3.30 billion on acquisitions and US$1.80 billion on share repurchases in 2025 to support its software-focused portfolio. Management also highlighted more than 25 generative AI initiatives that are already improving customer retention and are being scaled across Roper’s vertical software businesses to reinforce long-term cash flow growth. We’ll now examine...

Quaker Chemical (NYSE:KWR) has involuntarily terminated Senior Vice President and Chief Global Operations Officer Jeffrey Fleck. The departure affects a key executive role responsible for global operations oversight. This change represents a material event for the company’s leadership and operational continuity. Jeffrey Fleck’s exit comes at a time when Quaker Chemical’s share price stands at $118.45 and recent returns have been weak, with the stock down 8.6% over the past week and 33.4%...

If you are wondering whether SIGA Technologies is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock closed at US$5.26 most recently, with returns showing a 9.3% decline over 7 days, a 20.8% decline over 30 days, a 16.1% decline year to date, but a 4.1% gain over 1 year and a 23.6% gain over 3 years that contrasts with a more modest 5.3% gain over 5 years. Recent price moves are sitting against a broader...

In March 2026, American Tower Corporation announced that director Robert D. Hormats will not stand for re-election, raised its quarterly cash distribution to US$1.79 per share, and participated in Deutsche Bank’s 34th Annual Media, Internet & Telecom Conference. Investor attention has also been shaped by Bernstein’s initiation of coverage, which emphasized American Tower’s global tower portfolio and its CoreSite data center business as key pillars of the company’s business profile. With...